STOCKS | U.S. Markets Open Lower Amid Pharmaceutical Developments

U.S. stock markets opened with declines as the Dow Jones Industrial Average fell by 0.33%, the S&P 500 index dropped 0.15%, and the Nasdaq Composite decreased 0.13%. According to Jin10, Novo Nordisk experienced a significant drop of 15.65% following reports that its weight-loss drug, Cagrisema, did not perform as well in trials compared to Eli Lilly's Zepbound. In contrast, Eli Lilly's shares rose by 3.86% in response to the news.